Last reviewed · How we verify
Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis
The purpose of this study is to examine in children with persistent AR the effect of the topically applied beclomethasone in comparison with cetirizine on nasal patency evaluated by acoustic rhinometry and subjective nasal symptoms.
Details
| Lead sponsor | Stefania La Grutta, MD |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 68 |
| Start date | 2016-05 |
| Completion | 2017-07 |
Conditions
- Allergic Rhinitis
Interventions
- Nasal Beclomethasone Dipropionate
- CERCHIO 10 mg/ml OS
Primary outcomes
- Nasal patency evaluated by acoustic rhinometry. — 21 days
The main objective is to assess the increase of nasal patency in children aged 6-16 with perennial allergic rhinitis (PAR), treated with Beclometasone nasal spray 100 µg/die for 21 days.
Countries
Italy